The exceptional results obtained in GOT1 xenografts may thus indicate a possibility for more successful treatment of patients with metastatic carcinoid tumours than hitherto achieved in clinical series. This evidence concerns the gene GOT1 and digestive system neuroendocrine neoplasm.